Congratulations to one of our Alumni Jolyon Martin who has been named in the Science and Healthcare category on Forbes list of “30 under 30 in Europe" for his work as co-founder of PetMedix Ltd, a company bringing antibody therapeutics to veterinary medicine.
Each year Forbes ranks the world based on a variety of categories, ranging from the wealthiest people on the planet to the best colleges America has to offer. See Jolyon's profile in the Forbes Website.
Jolyon also told us how our DTP programme helped him on his journey:
"The DTP played an integral part in the founding of PetMedix. Through the willingness to fund a translational project, and the ability of the programme to draw on all of the bioscience related departments and institutions in Cambridge, I was able to get the broad intellectual support I needed, as well as the funding. Finally, my PIPS helped to give me a taste of the more commercial side of biotech, skills I now use every day."